Number of the records: 1
A Potential Radioimmunoconjugate 177Lu-DOTA-Bz-(h-R3) for Radioimmunotherapy of EGFR Overexpressing Tumors: Labeling Optimization and in vitro and in vivo Evaluations in Tumor Models
- 1.0356118 - ÚJF 2011 US eng A - Abstract
Beckford, Denis R. - Beran, Miloš - Eigner-Henke, Kateřina - Lázničková, A. - Lázníček, M. - Melichar, František
A Potential Radioimmunoconjugate 177Lu-DOTA-Bz-(h-R3) for Radioimmunotherapy of EGFR Overexpressing Tumors: Labeling Optimization and in vitro and in vivo Evaluations in Tumor Models.
European Journal of Nuclear Medicine and Molecular Imaging. Springer. Roč. 37, - (2010), S295-S295. ISSN 1619-7070. E-ISSN 1619-7089.
[23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). 09.10.2009-13.10.2010, Vienna]
R&D Projects: GA MŠMT OE08018
Institutional research plan: CEZ:AV0Z10480505
Keywords : Radioimmunoconjugate * EGFR * Tumor
Subject RIV: FR - Pharmacology ; Medidal Chemistry
Permanent Link: http://hdl.handle.net/11104/0194729
Number of the records: 1